Literature DB >> 25370280

Depression and borderline personality disorder.

Josephine A Beatson1, Sathya Rao2.   

Abstract

Borderline personality disorder (BPD) is a serious mental illness characterised by dysregulation of emotions and impulses, an unstable sense of self, and difficulties in interpersonal relationships, often accompanied by suicidal and self-harming behaviour. Major depressive disorder (MDD) commonly co-occurs with BPD. Patients with BPD often present with depressive symptoms. It can be difficult to distinguish between BPD and MDD, especially when the two disorders co-occur. Research is needed to clarify the commonalities and differences between BPD and MDD, and BPD and rapid-cycling bipolar disorder. When MDD and BPD co-occur, both conditions should be treated concurrently. MDD co-occurring with BPD does not respond as well to antidepressant medication as MDD in the absence of BPD. MDD is not a significant predictor of outcome for BPD, but BPD is a significant predictor of outcome for MDD. Treatment of BPD with specific psychotherapies tends to result in remission of co-occurring MDD. Empirically validated psychotherapies for BPD share common features that are applicable in all treatment settings where patients with BPD are likely to present, including primary care. Methodologically sound research is required to examine the effectiveness of medications for treatment of MDD co-occurring with BPD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 25370280     DOI: 10.5694/mja12.10474

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  Sleep-Wake Patterns of Adolescents with Borderline Personality Disorder and Bipolar Disorder.

Authors:  Christophe Huỳnh; Jean-Marc Guilé; Jean-Jacques Breton; Roger Godbout
Journal:  Child Psychiatry Hum Dev       Date:  2016-04

Review 2.  The prevalence of borderline personality features and borderline personality disorder during the perinatal period: a systematic review and meta-analysis.

Authors:  Divya Prasad; Nirushi Kuhathasan; Taiane de Azevedo Cardoso; Jee Su Suh; Benicio N Frey
Journal:  Arch Womens Ment Health       Date:  2022-02-26       Impact factor: 3.633

3.  A prospective, longitudinal, study of men with borderline personality disorder with and without comorbid antisocial personality disorder.

Authors:  Marie-Pier Robitaille; Dave Checknita; Frank Vitaro; Richard E Tremblay; Joel Paris; Sheilagh Hodgins
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2017-12-07

4.  Role of Electroconvulsive Therapy in Major Depressive Disorder with Borderline Personality Disorder: Case Report and Literature Review.

Authors:  Saad Wasiq; Ahmad R Khan; Amber E Faquih; Hina Saeed; Hafsa Mahmood
Journal:  Cureus       Date:  2018-08-27

5.  Core Symptoms of Major Depressive Disorder among Palliative Care Patients.

Authors:  Ng Su Huey; Ng Chong Guan; Jesjeet Singh Gill; Koh Ong Hui; Ahmad Hatim Sulaiman; Sharmilla Kunagasundram
Journal:  Int J Environ Res Public Health       Date:  2018-08-16       Impact factor: 3.390

6.  Unmet challenges in treating hypertension in patients with borderline personality disorder: A systematic review.

Authors:  Saara M Roininen; Marcus Cheetham; Beatrice U Mueller; Edouard Battegay
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Approach and Avoidance Behavior in Female Patients With Borderline Personality Disorder.

Authors:  Jana Wiesenfeller; Vera Flasbeck; Elliot C Brown; Martin Brüne
Journal:  Front Behav Neurosci       Date:  2020-12-01       Impact factor: 3.558

8.  Assessment of Borderline Personality Disorder in Geriatric Institutions.

Authors:  Franck Rexand-Galais; Lucas Pithon; Johane Le Goff
Journal:  Front Psychol       Date:  2021-03-23

9.  Disorder-specific characteristics of borderline personality disorder with co-occurring depression and its comparison with major depression: An fMRI study with emotional interference task.

Authors:  Natalia Chechko; Thilo Kellermann; Marc Augustin; Michael Zvyagintsev; Frank Schneider; Ute Habel
Journal:  Neuroimage Clin       Date:  2016-08-21       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.